Markets are getting ‘USED to this’: Kingsview Wealth Management CIO on the Iran conflict

Key Concepts

• Wartime Economy: An economic environment characterized by geopolitical instability and conflict, requiring defensive investment strategies.
• GLP-1 Agonists: A class of medications (e.g., Eli Lilly’s weight loss drugs) that mimic hormones to regulate appetite and blood sugar.
• AI Market Correction: The process of re-evaluating valuations for Artificial Intelligence companies based on actual revenue and user growth metrics.
• Defensive Investing: Allocating capital to stable, essential service sectors (like Waste Management) to hedge against market volatility.

1. The Wartime Economy and U.S. Market Resilience

Scott Martin, Chief Investment Management Officer at Kingsview, argues that investors must acclimate to a "wartime economy" due to ongoing tensions between the U.S. and Iran.

• Market Sentiment: Despite geopolitical friction, Martin suggests that the U.S. market is becoming desensitized to international conflict.
• Economic Indicators: He emphasizes that the domestic U.S. economy remains robust, citing strong consumer spending data, specifically referencing Visa’s performance as a proxy for consumer health.
• Perspective: Geopolitical distractions are viewed as secondary to the underlying strength of the U.S. economy.

2. AI Sector Analysis: Oracle and OpenAI

The discussion highlights a shift in investor sentiment regarding the AI boom, triggered by reports that OpenAI missed revenue and user growth targets.

• Market Reality: Martin notes that not every company in the AI space will be a winner, and firms like OpenAI and Anthropic are currently signaling caution.
• Oracle (ORCL) Case Study:
  • Valuation: Martin believes Oracle’s stock has been subject to extreme volatility, being both "overbought" and "oversold" at different intervals.
  • Price Target: He identifies a fair value range of $220–$225. With the stock trading near $160, he views the current dip as a potential entry point for upside growth.

3. Healthcare and GLP-1 Growth

The conversation highlights the dominance of GLP-1 weight loss drugs as a primary growth driver in the pharmaceutical sector, drawing a parallel between the investment hype surrounding AI and the pharmaceutical industry.

• Eli Lilly (LLY): Martin maintains a bullish stance on Eli Lilly, citing strong management, high-quality product pipelines, and consistent sales growth driven by weight loss medications.
• Strategic Outlook: He notes that his firm has been actively purchasing Eli Lilly stock throughout the month, anticipating a significant performance surge as the company scales its production and market reach.

4. Defensive Strategies: Waste Management

In anticipation of potential market downturns caused by escalating geopolitical tensions (specifically regarding Iran), Martin recommends defensive positioning.

• Waste Management (WM): Identified as a core component for a resilient portfolio.
• Rationale: Waste Management is categorized as a "nasty time" stock—a company that provides essential services, making it less susceptible to the volatility that impacts growth-oriented or speculative sectors during periods of international conflict.

Synthesis and Conclusion

The interview underscores a bifurcated investment strategy:

1. Growth/Speculative: While AI remains a focus, investors are advised to be selective, as the "AI hype" is undergoing a reality check regarding revenue growth. Companies like Oracle are viewed as opportunities if bought at the right valuation.
2. Healthcare: GLP-1 drugs represent a tangible, high-growth sector with strong fundamentals, exemplified by Eli Lilly.
3. Defensive: To mitigate risks associated with a "wartime economy," investors should anchor their portfolios with stable, essential-service companies like Waste Management.

Main Takeaway: The U.S. economy is fundamentally strong enough to withstand geopolitical distractions, but investors should pivot toward companies with proven product demand (GLP-1s) and defensive stability (Waste Management) while exercising caution with AI valuations that have outpaced actual growth metrics.